Literature DB >> 22582304

Intrapulmonary arteries respond to serotonin and adenosine triphosphate in broiler chickens susceptible to idiopathic pulmonary arterial hypertension.

H A Kluess1, J Stafford, K W Evanson, A J Stone, J Worley, R F Wideman.   

Abstract

This study examined factors contributing to increased vascular resistance and plexiform lesion formation in broiler chickens susceptible to idiopathic pulmonary arterial hypertension (IPAH). A diet supplemented with excess tryptophan (high-Trp diet), the precursor for serotonin, was used to accelerate the development of IPAH. Broilers fed the high-Trp diet had higher pulmonary arterial pressures than broilers fed the control diet, and plexiform lesion incidences tended to be higher (P = 0.11) in the high-Trp group than in the control group at 30 d of age. The intrapulmonary arteries were assessed for vasoconstriction in response to serotonin and adenosine triphosphate (ATP) and for activities of key metabolic enzymes for serotonin and ATP. The pulmonary artery (defined as the first major branch of the pulmonary artery inside the lung) and the primary pulmonary arterial rami (defined as the second major branch of the pulmonary artery inside the lung) both exhibited vasoconstriction in response to serotonin and ATP. This is the first study to demonstrate purinergic-mediated vasoconstriction in intrapulmonary arteries from broilers. Arteriole responsiveness did not differ between broilers fed the control diet or the high-Trp diet. Therefore, the high-Trp diet enhanced the development of IPAH but did not affect the artery's sensitivity to serotonin or ATP. Monoamine oxidase activity, responsible for the breakdown of serotonin, was severely impaired in pulmonary arteries from broilers in the high-Trp group. Accordingly, serotonin may persist longer and elicit an amplified response in broilers fed the high-Trp diet.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22582304      PMCID: PMC6854903          DOI: 10.3382/ps.2011-01919

Source DB:  PubMed          Journal:  Poult Sci        ISSN: 0032-5791            Impact factor:   3.352


  34 in total

1.  Idiopathic pulmonary arterial hypertension: an avian model for plexogenic arteriopathy and serotonergic vasoconstriction.

Authors:  Robert F Wideman; Krishna R Hamal
Journal:  J Pharmacol Toxicol Methods       Date:  2011-01-26       Impact factor: 1.950

2.  Estimates of individual factors of the tryptophan requirement based on protein and tryptophan accretion responses to increasing tryptophan supply in broiler chickens 8-21 days of age.

Authors:  Andrew A Fatufe; Frank Hirche; Markus Rodehutscord
Journal:  Arch Anim Nutr       Date:  2005-06       Impact factor: 2.242

3.  Plexiform lesions in the lungs of domestic fowl selected for susceptibility to pulmonary arterial hypertension: incidence and histology.

Authors:  Robert F Wideman; Krishna R Hamal; Michael T Bayona; Alberto G Lorenzoni; David Cross; Fariborz Khajali; Douglas D Rhoads; Gisela F Erf; Nicholas B Anthony
Journal:  Anat Rec (Hoboken)       Date:  2011-03-29       Impact factor: 2.064

4.  Crude protein and supplemental dietary tryptophan effects on growth and tissue neurotransmitter levels in the broiler chicken.

Authors:  R W Rosebrough
Journal:  Br J Nutr       Date:  1996-07       Impact factor: 3.718

5.  A robotics-based automated assay for inorganic and organic phosphates.

Authors:  E B Cogan; G B Birrell; O H Griffith
Journal:  Anal Biochem       Date:  1999-06-15       Impact factor: 3.365

6.  Pulmonary vascular pressure profiles in broilers selected for susceptibility to pulmonary hypertension syndrome: age and sex comparisons.

Authors:  R F Wideman; M L Eanes; K R Hamal; N B Anthony
Journal:  Poult Sci       Date:  2010-09       Impact factor: 3.352

7.  Evaluation of the serotonin receptor blocker methiothepin in broilers injected intravenously with lipopolysaccharide and microparticles.

Authors:  M E Chapman; R F Wideman
Journal:  Poult Sci       Date:  2006-12       Impact factor: 3.352

8.  Vasoconstriction of intrapulmonary arteries to P2-receptor nucleotides in normal and pulmonary hypertensive newborn piglets.

Authors:  M R McMillan; G Burnstock; S G Haworth
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

9.  Monoclonal endothelial cells in appetite suppressant-associated pulmonary hypertension.

Authors:  R M Tuder; Z Radisavljevic; K R Shroyer; J M Polak; N F Voelkel
Journal:  Am J Respir Crit Care Med       Date:  1998-12       Impact factor: 21.405

10.  Role of monoamine oxidases in the exaggerated 5-hydroxytryptamine-induced tension development of human isolated preeclamptic umbilical artery.

Authors:  Sai Wang Seto; Ho Yeung Lam; Wing Sze Lau; Alice L S Au; Tsz Yan Lam; Stephen S C Chim; Sai Ming Ngai; Shun Wan Chan; Tak Yeung Leung; John H K Yeung; Siu Kai Kong; George P H Leung; Simon M Y Lee; Yiu Wa Kwan
Journal:  Eur J Pharmacol       Date:  2009-03-01       Impact factor: 4.432

View more
  4 in total

1.  Plexogenic arteriopathy in broiler lungs: Evaluation of line, age, and sex influences.

Authors:  R F Wideman; J G Mason; N B Anthony; D Cross
Journal:  Poult Sci       Date:  2015-02-12       Impact factor: 3.352

2.  Potential contribution of early endothelial progenitor cell (eEPC)-to-macrophage switching in the development of pulmonary plexogenic lesion.

Authors:  Feng-Jin Shao; Xiao-Ling Guo; Jia-Xue Xu; Rui Liu; Dan-Yue Li; Qing-Hao Li; Ting Zhou; Cun Fang; Xun Tan
Journal:  Respir Res       Date:  2022-10-23

3.  MSC Transplantation Attenuates Inflammation, Prevents Endothelial Damage and Enhances the Angiogenic Potency of Endogenous MSCs in a Model of Pulmonary Arterial Hypertension.

Authors:  Fengjin Shao; Rui Liu; Xun Tan; Qiaoyan Zhang; Lujie Ye; Bingxuan Yan; Ying Zhuang; Jiaxue Xu
Journal:  J Inflamm Res       Date:  2022-03-30

4.  Purinergic Dysfunction in Pulmonary Arterial Hypertension.

Authors:  Zongye Cai; Ly Tu; Christophe Guignabert; Daphne Merkus; Zhichao Zhou
Journal:  J Am Heart Assoc       Date:  2020-09-01       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.